催化剂制药 CPRX 深 沪
已收盘 07-02 16:00:00 美东时间
31.45
+0.010
+0.03%
华盛通- 最 高31.47
- 今 开31.45
- 成交量 161.63万股
- 最 低 31.44
- 昨 收 31.44
- 总市值 38.50亿
- 52周最高 32.56
- 市盈率 静 18.67
- 换手率 1.32%
- 52周最低 19.05
- 委 比 95.80%
- 总股本 1.22亿
- 历史最高 32.56
- 量 比 0.64
- 振 幅 0.10%
- 历史最低 0.37
- 每 手 1
- 风险率 3.70%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Catalyst Pharma reports positive Phase 1 AGAMREE results
An announcement from Catalyst Pharma ( ($CPRX) ) is now available. On June 30, ...
07-01 05:18
Catalyst Pharma Gains FTC Clearance for Angelini Merger
Catalyst Pharma ( ($CPRX) ) has provided an announcement. On May 6, 2026, Catal...
06-24 06:58
As corporate profit margins remain elevated, these mid-caps stand out
With U.S. corporate profit margins remaining near historic highs, investors are increasingly focused on companies that have demonstrated an ability to consistently generate strong earnings and returns...
06-18 21:25
朝阳门并购堂 | 2026年5月并购重组市场观察
（来源：中信建投证券投行委） 一、新增重组事件 （一）华洋赛车(920058.BJ) 停牌筹划重组 （二）交大思诺(300851.SZ) 停牌筹划重组...
06-12 14:56
Dogecoin Price Hits Multi-Year Low: Is The Elon Musk Narrative Dead?
Dogecoin (CRYPTO: DOGE) is down 13% over the past week and 88% below its all-time high, as the Elon Musk correlation that drove the coin for years
06-10 03:37
Why Google's Multi-Year SpaceX Alliance Solidifies Its AI Leadership: Analyst
Alphabet stock moves as it signs a $920M monthly cloud deal with SpaceX to secure 110,000 NVIDIA GPUs for its AI computing pipeline.
06-10 00:59
Samsung may build chip packaging plant: report
Samsung (SSNLF) is looking into building a chip packaging plant in South Korea, Korean news outlet Economic Daily reported. The facility could be in the South Jeolla and Gwangju areas of the country, ...
06-09 20:49
Catalyst Pharmaceuticals Sets July 2026 Vote on $31.50-per-Share Angelini Pharma Buyout
New activity is brewing for Catalyst Pharma ( ($CPRX) ). The company has submit...
06-09 05:27
美股大行评级 | 瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
05-29 18:09
HC Wainwright & Co. Downgrades Catalyst Pharmaceuticals to Neutral, Lowers Price Target to $31.5
HC Wainwright & Co. analyst Andrew S. Fein downgrades Catalyst Pharmaceuticals (NASDAQ:CPRX) from Buy to Neutral and lowers the price target from $35 to $31.5.
05-29 00:43
